| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |